Cargando…

Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report

The proposed role of interleukin (IL)-17 in vitiligo pathogenesis, as well as the possible action of anti-IL-17A drugs on vitiligo, are not fully understood. The appearance of vitiligo as a paradoxical effect of treatment with anti-tumor necrosis factor-α drugs is an event well known in the literatu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Domenico, Magri, Francesca, Persechino, Flavia, Lepore, Alejandra, Verde, Romina, Capalbo, Alessandro, Persechino, Severino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Single Case
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488421/ https://www.ncbi.nlm.nih.gov/pubmed/34703429 http://dx.doi.org/10.1159/000510831

Ejemplares similares

Repigmentation of Tenacious Vitiligo on Apremilast
por: Huff, Sara B., et al.
Publicado: (2017)

Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
por: Rongioletti, Franco, et al.
Publicado: (2018)

Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib
por: Kim, Sa Rang, et al.
Publicado: (2021)

Repigmentation in a patient with vitiligo on crisaborole 2% ointment
por: Tam, Idy, et al.
Publicado: (2021)

Acute Vitiligo Repigmentation in the Setting of Suspected Pulmonary Sarcoidosis
por: Thrash, Brandon T., et al.
Publicado: (2022)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016)

Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

Use of Dermatoscope to Monitor the Repigmentation of Various Vitiligo Surgical Procedures
por: Nirmal, Balakrishnan
Publicado: (2016)

Repigmentation in a Vitiligo Universalis Patient: Chemotherapy-Induced or Spontaneous?
por: Kim, So Min, et al.
Publicado: (2017)

Repigmentation in vitiligo universalis after starting dialysis—could they be related?
por: Farahbakhsh, Navid, et al.
Publicado: (2018)

Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation()()
por: Komnitski, Melpone, et al.
Publicado: (2020)

What is successful repigmentation in vitiligo from the point of view of patients?
por: Narayan, V.S., et al.
Publicado: (2020)

Vitiligo Repigmentation After SARS-CoV-2 Vaccine
por: Bustos-Macaya, Roberto, et al.
Publicado: (2023)

A Review of the Use of Secukinumab for Psoriatic Arthritis
por: Patel, Nupur U., et al.
Publicado: (2017)

Correction to: Secukinumab: A Review in Psoriatic Arthritis
por: Blair, Hannah A.
Publicado: (2021)

Vitiligo and Autoimmune Thyroid Disorders
por: Baldini, Enke, et al.
Publicado: (2017)

Successful Repigmentation of Vitiligo-Like Hypopigmentation in a Case of Acanthosis Nigricans
por: Chun, Seung Hyun, et al.
Publicado: (2017)

Decreased expression of KGF/FGF7 and its receptor in pathological hypopigmentation
por: Purpura, Valeria, et al.
Publicado: (2014)

Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis
por: Kirby, Colm, et al.
Publicado: (2021)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
por: Matsuura-Otsuki, Yuki, et al.
Publicado: (2017)

Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
por: Li, Xinxin, et al.
Publicado: (2023)

Repigmentation of Segmental Vitiligo with Scalp and Pubic Follicular Unit Extraction Graft Transplantation
por: Pillai, Jisha, et al.
Publicado: (2023)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
por: Buchanan, Vanessa, et al.
Publicado: (2018)

Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis
por: Mendes Roncada, Eduardo V., et al.
Publicado: (2021)

Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review
por: Sisti, Andrea, et al.
Publicado: (2016)

A Novel Association Between Loop Diuretic Therapy and Repigmentation in Two Patients With Vitiligo
por: Arndt, Mary, et al.
Publicado: (2021)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis
por: CHELLI, Clara, et al.
Publicado: (2020)

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
por: Alegre-Sancho, Juan José, et al.
Publicado: (2023)

Remission of Kimura Disease With Carotid Hypervascularization After Cyclosporine Treatment
por: Persechino, Severino, et al.
Publicado: (2020)

Progression of Pre-Existing Vitiligo during Secukinumab Treatment for Psoriasis
por: Kim, Jin Cheol, et al.
Publicado: (2023)

Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
por: Todberg, Tanja, et al.
Publicado: (2020)

Rapid Partial Repigmentation of Vitiligo in a Young Female Adult with a Gluten-Free Diet
por: Khandalavala, Birgit N., et al.
Publicado: (2014)

Guselkumab-induced vitiligo in a patient with psoriatic arthritis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab
por: Herrero-Moyano, María, et al.
Publicado: (2018)

Real Life Efficacy and Safety of Secukinumab in Biologic-Experienced Patients With Psoriatic Arthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2020)

New-Onset Collagenous Colitis in a Patient With Psoriatic Arthritis: Can It Be Secukinumab?
por: Obeidat, Adham E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22b65u522gann32pp7qcttb18k